Curious -- what was disclosed at conference that would cause a sell off? | CNAT Message Board Posts

Conatus Pharmaceuticals Inc.

  CNAT website

CNAT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  3562 of 3577  at  4/15/2019 2:02:46 PM  by

MicroCupTraitor


 In response to msg 3560 by  A8bil1
view thread

Re: Curious -- what was disclosed at conference that would cause a sell off?

• Conatus Pharmaceuticals (CNAT -27.2%) slumps on double normal volume in reaction to results from a Phase 2 clinical trial, ENCORE-PH, evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension. The data were presented at The International Liver Congress in Vienna.
• Emricasan failed to sufficiently separate from placebo in terms of the mean change from baseline to week 24 in hepatic venous pressure gradient (HVPG), the primary endpoint (first announced in December 2018).
• On the safety front, 82.1% (n=55/67) of patients receiving emricasan experienced a drug-related adverse event, 55.2% (n=37/67) moderate or severe. The most common were peripheral edema (8 - 15% depending on the dose), nausea (9 - 12%) and urinary tract infection (8 - 15%).
• Shares plummeted over 50% in late March when the company announced that its ENCORE-HF study failed.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 164
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
3563 Re: Curious -- what was disclosed at conference that would cause a sell off? uptabdowntab 0 4/15/2019 2:30:54 PM
3564 Re: Curious -- what was disclosed at conference that would cause a sell off? uptabdowntab 0 4/15/2019 4:23:06 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...